Summary

text

INTRODUCTION TO CARDIAC BIOMARKERS AND ACS

• The ideal cardiac biochemical marker should be sensitive, specific, significant (right timing), and have prognostic value.
• Acute Coronary Syndrome (ACS) describes a range of conditions caused by reduced blood flow to the heart, including stable angina, unstable angina, Acute Myocardial Infarction (AMI), and Sudden Cardiac Death (SCD).
• Unstable Angina is characterized by chest pain without evidence of heart muscle damage.
• Acute Myocardial Infarction (AMI) is defined as heart muscle damage/necrosis due to a blockage in the coronary arteries.
• Cardiac markers are proteins released into the bloodstream when the heart muscle is damaged (myocyte necrosis).
• While ECG has limited sensitivity for ischemic injury, properly timed serial biochemical markers are the most clinically relevant assessment for myocardial necrosis.

COMPARATIVE KINETICS OF CARDIAC MARKERS

TROPONIN (cTnI and cTnT)

• Troponin I (cTnI) is considered the most specific marker for AMI.
• Cardiac Troponin consists of two releases: an immediate release of cytoplasmic troponin (within 4-8 hours) and a sustained release of bound troponin from degrading myofibrils (within 10-14 days).
• A single positive result for Troponin has high specificity for AMI, but serial testing is required because sensitivity is limited in the very early ( < 3 hours) or late (>12 hours) windows.
• Troponin is not elevated in skeletal muscle injury or vigorous exercise, unlike CK-MB and Myoglobin.
• In patients with Unstable Angina, increasing Troponin levels indicate a high risk of progression to AMI.
• In patients with Chronic Kidney Disease (CKD), Troponin T may be persistently slightly elevated due to reduced renal clearance and chronic myocardial stress.

CREATINE KINASE (CK) AND ISOENZYMES

• Creatine Kinase (CK) total levels are non-specific and can be elevated in AMI, muscular dystrophy, strenuous exercise, and CVA.
• CK-BB is the fastest migrating isoenzyme found primarily in the brain, bladder, and stomach.
• CK-MM is the slowest migrating isoenzyme found primarily in skeletal muscle.
• CK-MB is the isoenzyme found primarily in cardiac muscle (and some skeletal muscle).
• CK-MB is the marker of choice for diagnosing re-infarction because it returns to baseline within 48-72 hours.
• Serial measurements of CK-MB increase diagnostic sensitivity; a rising trend suggests acute or extension of infarction, while a falling trend suggests resolution.

MYOGLOBIN

• Myoglobin is the earliest marker of AMI, rising within 1-3 hours.
• Myoglobin has the highest sensitivity but the least specificity for heart injury, as it is found in all muscle tissue.
• A normal Myoglobin result within 2 hours of symptom onset has a high negative predictive value, effectively ruling out AMI.
• Myoglobin is a small protein soluble in the cytoplasm, allowing for rapid leakage through damaged membranes compared to larger proteins like Troponin.

OTHER BIOMARKERS (LDH, BNP, CRP, IMA)

• Lactate Dehydrogenase (LDH): In a healthy state, LDH-2 > LDH-1. In AMI, the pattern is "flipped" (LDH-1 > LDH-2).
• Aspartate Transaminase (AST): Formerly SGOT; begins rising in 6-8 hours, but is non-specific as it is found in the liver and heart.
• B-type Natriuretic Peptide (BNP): Secreted by ventricles in response to wall stretch/volume overload; excellent marker for Congestive Heart Failure (CHF).
• BNP levels < 100 pg/mL indicate no HF, while levels > 600 pg/mL indicate moderate HF.
• High-Sensitivity C-Reactive Protein (hs-CRP): A marker of low-grade inflammation and a strong predictor of future cardiovascular risk.
• An hs-CRP level > 3.0 mg/L indicates High Risk for future cardiovascular events; > 10 mg/L indicates an increased risk of recurrent events in unstable angina.
• Ischemia-Modified Albumin (IMA): A marker of active ischemia (reduced oxygen/tissue stress) rather than necrosis; rises before Troponin.
• IMA results from the reduced cobalt-binding capacity of albumin caused by an acidic, hypoxemic, or free-radical environment.

REPERFUSION AND RISK ASSESSMENT

• "Washout Phenomenon" (Cardiac Reperfusion): Occurs after successful treatment (like PCI) where cardiac markers rise/peak much faster and higher than in unperfused cases.
• In the Washout Phenomenon, the rapid flush of accumulated markers into systemic circulation reflects successful restoration of blood flow rather than a larger area of damage.
• GRACE Risk 2.0 is a clinical registry used to predict the risk of MI and death; it is considered more predictive than the TIMI score.
• Re-infarction is suspected if CK-MB rises again after it has already begun to decline toward its 48-72 hour baseline.

SPECIAL CLINICAL CONSIDERATIONS

• Exertional Rhabdomyolysis: Characterized by very high Total CK (e.g., 15,000 U/L) and dark urine, but Normal Troponin I (differentiating it from AMI).
• Silent MI in Diabetics: Poorly controlled diabetics may present with vague fatigue or indigestion instead of chest pain due to Diabetic Autonomic Neuropathy.
• Troponin T vs. Troponin I: Both are heart-specific, but Troponin T is more likely to be persistently elevated in Renal Failure/CKD.
• Acute Myocardial Infarction Diagnosis: Requires a Troponin level > 99th percentile plus a dynamic "rise and fall" (delta) and clinical/ECG evidence of ischemia.

KEY DIFFERENTIATORS FOR EXAMS

• Troponin I vs Myoglobin: Troponin I is the most specific (Gold Standard); Myoglobin is the most sensitive/earliest (Best for rule-out).
• CK-MB vs Troponin: CK-MB is the preferred choice for re-infarction due to its 3-day duration; Troponin is unreliable for re-infarction because it stays elevated for 10-14 days.
• IMA vs Troponin: IMA measures ischemia (loss of oxygen, reversible); Troponin measures necrosis (cell death, irreversible).
• LDH-1 vs LDH-2: Normal is LD2 > LD1; Myocardial Infarction is LD1 > LD2 (The "Flipped Ratio").
• BNP vs Troponin: BNP indicates ventricular stretch/heart failure; Troponin indicates ventricular damage/infarction.
• Standard CRP vs hs-CRP: Standard CRP (>10 mg/L) measures acute infection; hs-CRP (<10 mg/L) measures low-grade inflammation and cardiac risk.
• Chest Pain in AMI vs Unstable Angina: AMI has elevated cardiac markers; Unstable Angina has chest pain without elevated cardiac markers.
• Troponin in CKD vs AMI: In CKD, Troponin is persistently elevated without a dynamic change; in AMI, there is a clear "rise and fall" (delta).
• CK-MB in Rhabdomyolysis vs AMI: In skeletal muscle injury, Total CK is massively elevated with Normal Troponin; in AMI, CK-MB and Troponin are concordantly elevated.
• Early vs Late Presentation: Myoglobin is best for presentation < 3 hours; LDH and Troponin are best for presentation > 48 hours.

QA

text

1. What are the 4 qualities of an ideal Cardiac Biochemical Marker? | 1) Sensitive
   2) Specific
   3) Significant
   4) Prognostic value

2. Define Acute Coronary Syndrome (ACS). | Reduced blood flow. Range of conditions caused by reduced blood flow to the heart.

3. List the 4 conditions included under Acute Coronary Syndrome (ACS). | 1) Stable angina
   2) Unstable angina
   3) AMI
   4) Sudden Cardiac Death (SCD)

4. What characterizes Unstable Angina? | No heart damage. Chest pain without evidence of heart muscle damage.

5. Define Acute Myocardial Infarction (AMI). | Necrosis. Heart muscle damage/necrosis due to coronary artery blockage.

6. What are Cardiac Markers? | Released proteins. Proteins released into the bloodstream when the heart muscle is damaged.

7. What is the most clinically relevant assessment for Myocardial Necrosis? | Serial biochemical markers. Properly timed serial biochemical markers.

8. Why is ECG considered limited in ACS? | Limited sensitivity. ECG has limited sensitivity for ischemic injury.

9. What is the tissue source of Myoglobin? | Heart & Skeletal Muscle.

10. How quickly does Myoglobin increase after injury? | 1-3 hours.

11. What is the peak time for Myoglobin? | 8-12 hours.

12. What is the duration of elevation for Myoglobin? | Within 24 hours.

13. What is the primary clinical utility of Myoglobin? | Earliest marker. High negative predictive value to rule-out.

14. What is the tissue source of Troponin (cTnI/cTnT)? | Heart.

15. How quickly does Troponin increase? | 3-4 hours.

16. What is the peak time for Troponin? | 24 hours.

17. What is the duration of elevation for Troponin? | 10-14 days.

18. What is the primary clinical utility of Troponin? | Most specific. Gold standard for AMI diagnosis.

19. What is the tissue source of CK-MB? | Heart & Skeletal Muscle.

20. How quickly does CK-MB increase? | 3-6 hours.

21. What is the peak time for CK-MB? | 12-24 hours.

22. What is the duration of elevation for CK-MB? | 48-72 hours.

23. What is the primary clinical utility of CK-MB? | Re-infarction. Useful because it clears quickly.

24. What is the tissue source of LDH? | Multiple sources. Heart, RBCs, Liver, etc.

25. How quickly does LDH increase? | 12-24 hours.

26. What is the peak time for LDH? | 48-72 hours.

27. What is the duration of elevation for LDH? | 10-14 days.

28. What is the primary clinical utility of LDH? | Late presenters.

29. What is the tissue source of AST? | Multiple sources. Heart, Liver, RBCs, Muscle.

30. How quickly does AST increase? | 6-8 hours.

31. What is the duration of elevation for AST? | 5 days.

32. What is the clinical utility of AST? | Non-specific. Indicates general inflammation/injury.

33. Which marker is considered the "most specific" for AMI? | Troponin I (cTnI).

34. Name the two releases of Cardiac Troponin. | Immediate and Sustained. 1) Immediate cytoplasmic release
    2) Sustained release from degrading myofibrils.

35. What is the timing for the Immediate Release of cytoplasmic troponin? | 4-8 hours.

36. What is the timing for the Sustained Release of bound troponin? | 10-14 days.

37. Why is serial testing required for Troponin? | Limited sensitivity. Sensitivity is limited in very early (<3 hours) or late (>12 hours) windows.

38. Is Troponin elevated in skeletal muscle injury or vigorous exercise? | No. Unlike CK-MB and Myoglobin, it is not elevated.

39. What do increasing Troponin levels indicate in Unstable Angina? | High risk. Indicates high risk of progression to AMI.

40. Why is Troponin T persistently elevated in Chronic Kidney Disease (CKD)? | Reduced renal clearance. Due to reduced renal clearance and chronic myocardial stress.

41. Why are Total CK levels considered non-specific? | Multiple sources. Can be elevated in AMI, muscular dystrophy, exercise, and CVA.

42. What is the fastest migrating CK isoenzyme and its source? | CK-BB. Found primarily in the brain, bladder, and stomach.

43. What is the slowest migrating CK isoenzyme and its source? | CK-MM. Found primarily in skeletal muscle.

44. Where is CK-MB primarily found? | Cardiac muscle. And some skeletal muscle.

45. Why is CK-MB the marker of choice for re-infarction? | Returns to baseline quickly. It clears within 48-72 hours.

46. In CK-MB serial measurements, what does a "rising trend" suggest? | Acute/Extension of infarction.

47. In CK-MB serial measurements, what does a "falling trend" suggest? | Resolution.

48. Which Cardiac Marker is the earliest to rise? | Myoglobin. Rises within 1-3 hours.

49. Describe the sensitivity and specificity of Myoglobin. | Highest sensitivity; least specificity.

50. What is the clinical value of a normal Myoglobin within 2 hours of symptoms? | High negative predictive value. Effectively rules out AMI.

51. Why does Myoglobin leak rapidly through damaged membranes? | Small protein. It is a small protein soluble in the cytoplasm.

52. Describe the "flipped" pattern of LDH in AMI. | LDH-1 > LDH-2.

53. What is the normal relationship between LDH-1 and LDH-2 in a healthy state? | LDH-2 > LDH-1.

54. What was the former name of Aspartate Transaminase (AST)? | SGOT.

55. Where is B-type Natriuretic Peptide (BNP) secreted from? | Ventricles.

56. What triggers the release of BNP? | Wall stretch/volume overload.

57. BNP is an excellent marker for what condition? | Congestive Heart Failure (CHF).

58. What BNP level indicates no Heart Failure exists? | < 100 pg/mL.

59. What BNP level indicates moderate Heart Failure? | > 600 pg/mL.

60. What does hs-CRP stand for? | High-Sensitivity C-Reactive Protein.

61. What does hs-CRP measure? | Low-grade inflammation. Predictor of future cardiovascular risk.

62. What hs-CRP level indicates "High Risk" for future cardiovascular events? | > 3.0 mg/L.

63. What hs-CRP level indicates increased risk of recurrent events in unstable angina? | > 10 mg/L.

64. What does Ischemia-Modified Albumin (IMA) measure? | Active ischemia. Rises before Troponin and signifies reduced oxygen/tissue stress.

65. What causes the change in Albumin in IMA? | Reduced cobalt-binding. Caused by acidic, hypoxemic, or free-radical environment.

66. Define the Washout Phenomenon. | Rapid marker rise. Occurs after successful treatment like PCI.

67. What does the Washout Phenomenon reflect clinically? | Successful restoration of flow. Reflects restoration of blood flow rather than larger damage.

68. What clinical registry is used to predict the risk of MI and death? | GRACE Risk 2.0.

69. Which score is GRACE Risk 2.0 considered more predictive than? | TIMI score.

70. When is Re-infarction suspected during serial monitoring? | CK-MB rises again. After it has already begun to decline toward its baseline.

71. What findings define Exertional Rhabdomyolysis? | Very high Total CK (15,000 U/L) and dark urine.

72. How is Exertional Rhabdomyolysis differentiated from AMI? | Normal Troponin I. Total CK is high but Troponin I remains normal.

73. How do Diabetic Patients commonly present during a "Silent MI"? | Vague fatigue or indigestion. Instead of chest pain.

74. Why do diabetics experience Silent MI? | Diabetic Autonomic Neuropathy.

75. Which Troponin is more likely to be persistently elevated in Renal Failure (CKD)? | Troponin T.

76. What are the 3 requirements for AMI Diagnosis? | 1) Troponin > 99th percentile
    2) Dynamic rise/fall (delta)
    3) Evidence of ischemia (clinical/ECG).

77. Compare Troponin I vs Myoglobin in terms of utility. | Troponin I: Most specific (Gold Standard).
    Myoglobin: Most sensitive/earliest (Rule-out).

78. Why is CK-MB preferred over Troponin for re-infarction? | Shorter duration. CK-MB lasts 3 days; Troponin stays elevated 10-14 days.

79. Compare IMA vs Troponin mechanism. | IMA: Ischemia (reversible).
    Troponin: Necrosis (irreversible).

80. Contrast the LDH-1 vs LDH-2 ratio in health vs MI. | Health: LD2 > LD1.
    MI: LD1 > LD2 (Flipped).

81. Contrast the indication for BNP vs Troponin. | BNP: Ventricular stretch/HF.
    Troponin: Ventricular damage/infarction.

82. Contrast Standard CRP vs hs-CRP. | Standard: Acute infection (>10 mg/L).
    hs-CRP: Cardiac risk (<10 mg/L).

83. Contrast chest pain in AMI vs Unstable Angina based on markers. | AMI: Elevated markers.
    Unstable Angina: No elevated markers.

84. Contrast Troponin in CKD vs AMI patterns. | CKD: Persistently elevated (no delta).
    AMI: Dynamic rise and fall (delta).

85. Contrast CK-MB in Rhabdomyolysis vs AMI. | Rhabdo: Massively elevated Total CK with Normal Troponin.
    AMI: Concordant elevation of CK-MB and Troponin.

86. Which marker should be used for presentation &lt 3 hours? | Myoglobin.

87. Which markers should be used for presentation > 48 hours? | LDH and Troponin.

88. Ideal Marker Quality: What does "Significant" refer to? | Right timing.

89. Cardiac markers: What event triggers their release? | Myocyte necrosis. Heart muscle damage.

90. Troponin I (cTnI): Where is its specific tissue source? | Heart.

91. Creatine Kinase (CK) total levels: Name 4 conditions where they rise. | 1) AMI
    2) Muscular dystrophy
    3) Strenuous exercise
    4) CVA

92. Myoglobin solubility: Where is it located within the cell? | Cytoplasm.

93. Ischemia-Modified Albumin (IMA): How does it compare to Troponin timing? | Rises before Troponin.

94. Washout Phenomenon: How do levels peak compared to unperfused cases? | Faster and higher.

95. Troponin T: Is it considered heart-specific? | Yes. Heart-specific but prone to elevation in CKD.

96. Unstable Angina: What is the primary characteristic of markers? | Not elevated. Chest pain without heart damage evidence.

97. Myoglobin: What is its primary disadvantage? | Least specificity. Found in all muscle tissue.

98. LDH: At what stage of presentation is it most useful? | Late presenters.

99. BNP: Does it measure infarction? | No. It indicates ventricular stretch/heart failure.

100. hs-CRP: Is it used to diagnose acute infection? | No. Standard CRP is for infection; hs-CRP is for cardiac risk.

101. CK-MB baseline: When does it return to baseline after AMI? | 48-72 hours.

102. Troponin baseline: When does it return to baseline after AMI? | 10-14 days.

103. AST: What is the tissue source (4)? | 1) Heart
     2) Liver
     3) RBCs
     4) Muscle

104. AMI Definition: What kind of blockage causes it? | Blockage in coronary arteries.

105. CK-MM: What type of migration does it exhibit on electrophoresis? | Slowest migrating.

106. CK-BB: What type of migration does it exhibit on electrophoresis? | Fastest migrating.

107. Myoglobin Peak: When does it reach its highest concentration? | 8-12 hours.

108. Troponin Elevation: Can it be elevated by exercise? | No. Unlike CK-MB/Myoglobin.

109. BNP vs HF: What is the significance of BNP > 600? | Moderate HF.

110. IMA Environment: Name 3 factors that reduce albumin's binding capacity. | 1) Acidic
     2) Hypoxemic
     3) Free-radical environment

111. Re-infarction Detection: Which marker is the preferred choice? | CK-MB.

112. Rule-out Protocol: Which marker provides a high negative predictive value? | Myoglobin.

113. Kinetics Table: Which marker stays elevated the longest (10-14 days)? | Troponin and LDH.

114. Kinetics Table: Which marker has the shortest duration of elevation? | Myoglobin (Within 24 hours).

115. AST elevation timing: When does it begin rising? | 6-8 hours.

116. CK-MB trend: What does a falling trend suggest? | Resolution of infarction.

117. Troponin Delta: Why is the "rise and fall" necessary for diagnosis? | To differentiate from chronic elevation (like CKD).

118. IMA marker type: Does it measure necrosis or ischemia? | Ischemia.

119. LDH-1 and LDH-2: Which one is normally higher in circulation? | LDH-2.

120. Exertional Rhabdomyolysis: What color is the urine? | Dark urine. due to myoglobinuria.

LFT

Summary

Topic: Liver Function Tests (LFTs) & Hepatocellular Enzymes

• In Liver Function Tests, ALT (Alanine Aminotransferase) is primarily a marker of hepatocyte injury and is more specific to the liver than AST.
• In Liver Function Tests, AST (Aspartate Aminotransferase) is found in the heart, liver, skeletal muscle, kidney, and brain; its highest concentration is in the heart.
• In Liver Function Tests, DeRitis Ratio (AST/ALT Ratio) is normally < 1; however, a ratio > 1 suggests severe damage involving the mitochondria, typically seen in Alcoholic abuse and Cirrhosis.
• In Liver Function Tests, AST t1/2 is approximately 16-18 hours, whereas ALT t1/2 is significantly longer at 40-48 hours.
• In Liver Function Tests, Transaminase elevations > 3x ULN are rarely observed in nonhepatic diseases, with Rhabdomyolysis being a notable exception.
• In Liver Function Tests, Viral Hepatitis typically presents with ALT > AST, while Alcoholic Hepatitis presents with AST > ALT.
• In Liver Function Tests, Lactate Dehydrogenase (LD) isoenzymes LD4 and LD5 are the slowest markers and are specifically elevated in liver damage or skeletal muscle insults.
• In Liver Function Tests, an LD1 > LD2 ratio is referred to as a "Flipped LD Ratio" and indicates Myocardial Infarction (MI), Hemolysis, or Renal Infarction.

Topic: Biliary Excretory Function & Ammonia

• In LFT interpretation, Alkaline Phosphatase (ALP) elevation is highly sensitive for Cholestatic or Infiltrative (Metastatic) liver disease.
• In LFT interpretation, GGT and 5’ Nucleotidase are used as adjunctive tests; if normal when ALP is high, the excess ALP is likely of bone origin.
• In differentiating ALP sources via heat inactivation, Bone ALP is 90% inactivated ("Bone Burns"), while Placental ALP is resistant to L-phenylalanine inhibition.
• In LFT interpretation, Regan Isoenzyme is a form of ALP identical to the placental type found in some patients with malignant disease.
• In LFT interpretation, GGT (Gamma-Glutamyl Transferase) is a sensitive indicator of biliary injury and alcohol use; levels typically return to normal in 3 weeks after abstinence.
• In Liver Function Tests, Ammonia levels are used to assess hepatic dysfunction and are associated with Asterixis (flapping tremor) in hepatic encephalopathy.
• For accurate Ammonia measurement, the specimen must be placed on ice, have no hemolysis, and the patient must abstain from smoking several hours prior.

Topic: Bilirubin Metabolism & Hyperbilirubinemia

• In Bilirubin metabolism, Unconjugated (Indirect) Bilirubin is water-insoluble, bound to albumin, and produced from heme breakdown via macrophages.
• In Bilirubin metabolism, Conjugated (Direct) Bilirubin is water-soluble, processed by the enzyme UDP-glucuronosyltransferase (UGT1A1) in the liver.
• In Clinical Diagnosis, Bilirubinuria always indicates Conjugated Hyperbilirubinemia because unconjugated bilirubin is not water-soluble.
• In prolonged jaundice, Delta-Bilirubin (D-albumin) is formed when conjugated bilirubin covalently links to albumin; it is unexcretable and persists after the underlying cause resolves.
• In Clinical Diagnosis, Acholic/Silver Stool (Thomas Stool) indicates complete biliary obstruction due to lack of stercobilin.

Topic: Neonatal Jaundice

• In pediatrics, Physiologic Neonatal Jaundice occurs due to immature liver function (low UGT).
• Physiologic Jaundice typically appears between days 2-3 of life, peaks by day 4-5, and rarely exceeds 20 mg/dL.
• In pediatrics, Kernicterus is the deposition of unconjugated bilirubin in brain structures like the basal ganglia and hippocampus due to a poorly developed Blood-Brain Barrier.
• In pediatrics, Phototherapy is used for unconjugated hyperbilirubinemia to convert bilirubin into a soluble molecule for excretion; it is not useful for conjugated hyperbilirubinemia.
• Pathologic Neonatal Jaundice is suspected if jaundice occurs within the first 24 hours of life or if total bilirubin is > 12 mg/dL.

Topic: Viral Hepatitis Serology (HBV, HCV, and others)

• In Hepatitis diagnosis, HBsAg (Surface Antigen) is the first marker to appear; it indicates active infection and infectivity.
• In Hepatitis diagnosis, Anti-HBs (Surface Antibody) indicates immunity from either a past infection or a vaccination.
• In Hepatitis diagnosis, IgM Anti-HBc is the hallmark of Acute Infection and may be the sole positive marker during the "window period."
• In Hepatitis diagnosis, HBeAg (e-Antigen) indicates active viral replication and high infectivity.
• In Hepatitis diagnosis, Chronic HBV infection is defined by the persistence of HBsAg for over 6 months.
• In Hepatitis diagnosis, Hepatitis C (HCV) has a chronicity rate of > 80%; HCV RNA is the best predictor of treatment response.
• In Hepatitis diagnosis, Hepatitis D (HDV) is a Superinfection or co-infection that only occurs in the presence of HBV.
• In Hepatitis diagnosis, Hepatitis E (HEV) is similar to HAV (fecal-oral) but is significantly more virulent in pregnant women (30% mortality).

Topic: HBV Genome & Specialist Diagnosis

• In molecular genetics, the HBV S Gene encodes the surface antigen (HBsAg), while the C Gene encodes both HBcAg and HBeAg.
• In diagnosis, Pre-core mutations (e.g., nucleotide position 1896 substitution) can stop HBeAg synthesis, leading to HBeAg-negative chronic hepatitis with high viral loads and poor prognosis.
• In Hepatitis C management, the Viral Genotype is the most important predictor of treatment response; Genotypes 2 and 3 respond better than Genotype 1.
• In Hepatic pathology, Liver Biopsy is the gold standard for assessing the degree of inflammation (grade) and stage of fibrosis in HCV.
• In systemic infections, the liver can be secondarily involved by EBV, CMV, HSV, and Yellow Fever.

Topic: Comparison & Differentiating Features

• Compare Hepatocellular vs. Cholestatic Jaundice: Hepatocellular shows ALT/AST > 3x ULN with ALP < 3x ULN; Cholestatic shows ALP > 3x ULN and transaminases < 3x ULN.
• Compare Gilbert vs. Crigler-Najjar Type I: Gilbert is benign and affects adults; Crigler-Najjar Type I is a complete absence of enzyme, causing infant death via Kernicterus.
• Compare Dubin-Johnson vs. Rotor Syndrome: Dubin-Johnson presents with a grossly black liver; Rotor syndrome does not.
• Compare AST vs. ALT: ALT is more liver-specific; AST is found in mitochondria and is higher in alcoholic liver disease.
• Compare HBV Immunity via Infection vs. Vaccine: Immunity from infection shows (+) Anti-HBs and (+) Anti-HBc; immunity from vaccine shows (+) Anti-HBs only.
• Compare HAV vs. HEV: Both are fecal-oral and acute; however, HEV is far more dangerous to pregnant women.
• Compare PT vs. Albumin: PT is a better indicator of acute/fulminant liver failure due to a short factor half-life (~12h); Albumin is for chronic assessment (t1/2 ~20 days).
• Compare Pre-hepatic vs. Post-hepatic Jaundice: Pre-hepatic involves hemolysis and high indirect bilirubin; Post-hepatic involves obstruction, high direct bilirubin, and pruritus.
• Compare HCV Quantitative vs. Qualitative Testing: Quantitative RNA monitors treatment response (best predictor); Qualitative is used for diagnosis.
• Compare GGT vs. ALP: Both rise in biliary disease, but GGT does not rise in bone disease, making it a "confirmatory" test for hepatic ALP origin.
• Compare Wilson's Disease vs. Hemochromatosis: Wilson’s is a defect in Copper (low ceruloplasmin); Hemochromatosis involves iron overload.
• Compare HBV Window Period Serology: The patient will be negative for both HBsAg and Anti-HBs; IgM Anti-HBc is the only marker of infection.

QA

Topic: Liver Function Tests (LFTs) & Hepatocellular Enzymes

1. In Liver Function Tests, what does ALT (Alanine Aminotransferase) primarily mark? | Hepatocyte injury.
   It is more specific to the liver than AST.
2. How does the liver specificity of ALT (Alanine Aminotransferase) compare to AST? | More specific.
   ALT is more specific to the liver than AST.
3. In Liver Function Tests, where is AST (Aspartate Aminotransferase) found? (5) | Heart, liver, skeletal muscle, kidney, and brain.
4. Where is the highest concentration of AST (Aspartate Aminotransferase) located? | The heart.
5. In Liver Function Tests, what is the normal DeRitis Ratio (AST/ALT Ratio)? | < 1.
6. What does a DeRitis Ratio (AST/ALT Ratio) > 1 suggest? | Severe mitochondrial damage.
   Typically seen in alcoholic abuse and cirrhosis.
7. Which conditions (2) are typically associated with a DeRitis Ratio > 1? | Alcoholic abuse and Cirrhosis.
8. What is the approximate half-life of AST (t1/2)? | 16-18 hours.
9. What is the approximate half-life of ALT (t1/2)? | 40-48 hours.
10. In Liver Function Tests, which enzyme has a longer half-life: AST or ALT? | ALT.
    ALT (40-48h) is significantly longer than AST (16-18h).
11. Transaminase elevations > 3x ULN are rarely seen in nonhepatic diseases except for which condition? | Rhabdomyolysis.
12. In Liver Function Tests, what is the typical ratio of AST and ALT in Viral Hepatitis? | ALT > AST.
13. In Liver Function Tests, what is the typical ratio of AST and ALT in Alcoholic Hepatitis? | AST > ALT.
14. Which Lactate Dehydrogenase (LD) isoenzymes are specifically elevated in liver damage? | LD4 and LD5.
15. What are the slowest markers of liver damage among Lactate Dehydrogenase (LD) isoenzymes? | LD4 and LD5.
16. What does a Flipped LD Ratio (LD1 > LD2) indicate? (3) | MI, Hemolysis, Renal Infarction.
17. What is the normal range for AST (SGOT)? | 8-33 U/L.
18. What is the primary significance of measuring AST (SGOT)? | Hepatocyte Integrity.
19. What is a unique feature of AST (SGOT) regarding its location? | Found in Mitochondria.
    Also found in the heart and leaks in severe injury.
20. What is the normal range for ALT (SGPT)? | 4-36 U/L.
21. What is the primary significance of measuring ALT (SGPT)? | Hepatocyte Integrity.
22. Where is ALT (SGPT) localized within the cell? | Cytoplasm.
    It is more liver-specific than AST.
23. What is the normal range for ALP (Alkaline Phosphatase)? | 20-130 U/L.
24. What are the primary significances of measuring ALP? (2) | Biliary Excretion / Bone.
25. Where is ALP concentrated in the body? (4) | Bone, liver, intestine, placenta.
26. What is the normal range for GGT (Gamma-Glutamyl Transferase)? | 5-40 U/L.
27. What are the primary significances of measuring GGT? (2) | Biliary Injury / Toxin.
28. GGT is a marker for the consumption of what substance? | Alcohol.
    GGT is induced by SER toxins.
29. What is the normal range for Ammonia? | 20-120 ug/dL.
30. What is the primary significance of measuring Ammonia? | Hepatic Metabolism.
31. What neurological sign is associated with high Ammonia? | Asterixis.
    Ammonia is highly neurotoxic.
32. What is the normal range for PT (Prothrombin Time)? | 10-13 sec.
33. What is the primary significance of measuring PT? | Synthetic Function.
34. Why is PT a better marker for acute or fulminant injury? | Short factor half-life (~12h).
35. What is the normal range for Albumin? | 3.2-4.5 g/dL.
36. What is the primary significance of measuring Albumin? | Synthetic Function.
37. Why does Albumin lack sensitivity in chronic liver disease? | Normal in 50% cirrhosis.
    Has a long half-life of ~20 days.

Topic: Biliary Excretory Function & Ammonia

38. Elevation of Alkaline Phosphatase (ALP) is highly sensitive for which liver disease types? (2) | Cholestatic or Infiltrative.
    Infiltrative includes metastatic disease.
39. Which tests are used as adjunctive tests to differentiate the source of high ALP? (2) | GGT and 5’ Nucleotidase.
40. If GGT is normal and ALP is high, what is the likely origin of the ALP? | Bone origin.
41. In heat inactivation, what percentage of Bone ALP is inactivated? | 90% inactivated.
    Mnemonic: "Bone Burns."
42. Which ALP isoenzyme is resistant to L-phenylalanine inhibition? | Placental ALP.
43. What is the Regan Isoenzyme? | Malignant ALP form.
    It is identical to the placental type found in malignant disease.
44. GGT (Gamma-Glutamyl Transferase) is a sensitive indicator of which two conditions? | Biliary injury and Alcohol.
45. How long does it take for GGT levels to return to normal after alcohol abstinence? | 3 weeks.
46. What is Ammonia levels used to assess in liver patients? | Hepatic dysfunction.
47. What is the flapping tremor associated with Ammonia toxicity called? | Asterixis.
48. What specimen handling is required for accurate Ammonia measurement? | Placed on ice.
49. What interference must be avoided in a specimen for Ammonia measurement? | No hemolysis.
50. What must a patient abstain from prior to Ammonia measurement? | Smoking.
    Abstain several hours prior.

Topic: Bilirubin Metabolism & Hyperbilirubinemia

51. What are the characteristics of Unconjugated (Indirect) Bilirubin? (3) | Water-insoluble, albumin-bound, from heme.
52. What are the characteristics of Conjugated (Direct) Bilirubin? (2) | Water-soluble, liver-processed.
53. Which enzyme converts unconjugated bilirubin to Conjugated Bilirubin? | UDP-glucuronosyltransferase (UGT1A1).
54. What does the presence of Bilirubinuria always indicate? | Conjugated Hyperbilirubinemia.
    Unconjugated bilirubin is not water-soluble.
55. What is Delta-Bilirubin (D-albumin)? | Bilirubin covalently linked to albumin.
56. When does Delta-Bilirubin typically form? | Prolonged jaundice.
57. Why does Delta-Bilirubin persist after the underlying cause of jaundice resolves? | It is unexcretable.
58. What does Acholic/Silver Stool (Thomas Stool) indicate? | Complete biliary obstruction.
59. Why is Acholic Stool pale or silver? | Lack of stercobilin.
60. What is the enzyme defect in Gilbert Syndrome? | Mildly decreased UGT.
61. What type of bilirubin is elevated in Gilbert Syndrome? | Unconjugated.
62. What triggers jaundice in Gilbert Syndrome? | Fasting or stress.
63. What is the enzyme defect in Crigler-Najjar Type I? | Absent UGT.
64. What type of bilirubin is elevated in Crigler-Najjar Type I? | Unconjugated.
65. What is the major clinical risk of Crigler-Najjar Type I in infants? | Kernicterus.
    It is fatal in infancy without treatment.
66. What is the defect in Dubin-Johnson Syndrome? | Excretory defect.
67. What type of bilirubin is elevated in Dubin-Johnson Syndrome? | Conjugated.
68. What is the hallmark physical finding in Dubin-Johnson Syndrome? | Grossly black liver.
69. What is the defect in Rotor Syndrome? | Transport defect.
70. What type of bilirubin is elevated in Rotor Syndrome? | Conjugated.
71. How do you differentiate Rotor Syndrome from Dubin-Johnson? | No black liver.

Topic: Neonatal Jaundice

72. What is the cause of Physiologic Neonatal Jaundice? | Immature liver function.
    Specifically low UGT activity.
73. When does Physiologic Jaundice typically appear? | Days 2-3 of life.
74. When does Physiologic Jaundice usually peak? | Days 4-5.
75. What is the typical bilirubin limit for Physiologic Jaundice? | Rarely exceeds 20 mg/dL.
76. What is Kernicterus? | Bilirubin deposition in brain.
77. Where is bilirubin deposited in Kernicterus? (2) | Basal ganglia and hippocampus.
78. Why are neonates susceptible to Kernicterus? | Poorly developed Blood-Brain Barrier.
79. What is the purpose of Phototherapy in neonates? | Converts bilirubin for excretion.
    Makes it a soluble molecule.
80. For which type of hyperbilirubinemia is Phototherapy NOT useful? | Conjugated hyperbilirubinemia.
81. Pathologic Neonatal Jaundice is suspected if jaundice occurs within what timeframe? | First 24 hours of life.
82. Pathologic Neonatal Jaundice is suspected if total bilirubin exceeds what value? | > 12 mg/dL.

Topic: Viral Hepatitis Serology (HBV, HCV, and others)

83. Which marker is the first to appear in Hepatitis B diagnosis? | HBsAg (Surface Antigen).
84. What does the presence of HBsAg indicate? | Active infection and infectivity.
85. What does the presence of Anti-HBs (Surface Antibody) indicate? | Immunity.
    From past infection or vaccination.
86. What is the hallmark serological marker of Acute HBV Infection? | IgM Anti-HBc.
87. Which marker might be the sole positive indicator during the HBV window period? | IgM Anti-HBc.
88. What does the presence of HBeAg (e-Antigen) indicate? | Active viral replication.
    Indicates high infectivity.
89. How is Chronic HBV infection defined serologically? | HBsAg persistence > 6 months.
90. What is the chronicity rate of Hepatitis C (HCV)? | > 80%.
91. Which test is the best predictor of treatment response in Hepatitis C (HCV)? | HCV RNA.
92. Hepatitis D (HDV) can only occur in the presence of which other virus? | HBV (Hepatitis B).
93. What are the two types of Hepatitis D (HDV) infection? (2) | Superinfection or co-infection.
94. How is Hepatitis E (HEV) transmitted? | Fecal-Oral.
95. In which population is Hepatitis E (HEV) significantly more virulent? | Pregnant women.
    30% mortality rate.
96. What is the virus family of HAV? | Picornavirus.
97. What is the transmission route and acute marker for HAV? | Fecal-Oral; IgM anti-HAV.
98. What is the virus family of HBV? | Hepadnaviridae.
99. What are the transmission routes for HBV? (2) | Parenteral and Sexual.
100. What is the chronicity rate of HBV in adults? | ~5-10%.
101. What is the virus family of HCV? | Flaviviridae.
102. What is the virus family of HDV? | Deltavirus.
103. What is the virus family of HEV? | Hepeviridae.

Topic: HBV Genome & Specialist Diagnosis

104. What does the HBV S Gene encode? | Surface antigen (HBsAg).
105. What does the HBV C Gene encode? (2) | HBcAg and HBeAg.
106. What occurs at nucleotide position 1896 in an HBV Pre-core mutation? | Substitution stopping HBeAg synthesis.
107. What are the clinical features of HBeAg-negative chronic hepatitis? | High viral loads/poor prognosis.
108. In Hepatitis C management, what is the most important predictor of treatment response? | Viral Genotype.
109. Which HCV Genotypes respond better to treatment? | Genotypes 2 and 3.
     They respond better than Genotype 1.
110. What is the gold standard for assessing inflammation grade and fibrosis stage in HCV? | Liver Biopsy.
111. Which systemic viruses can secondarily involve the liver? (4) | EBV, CMV, HSV, Yellow Fever.

Topic: Comparison & Differentiating Features

112. Compare Hepatocellular vs. Cholestatic Jaundice laboratory findings. | Hepatocellular: Transaminases > 3x ULN.
     Cholestatic: ALP > 3x ULN.
113. Compare Gilbert vs. Crigler-Najjar Type I in terms of outcome. | Gilbert: Benign/Adult.
     Crigler-Najjar: Infant death/Kernicterus.
114. Compare Dubin-Johnson vs. Rotor Syndrome liver appearance. | Dubin-Johnson: Grossly black liver.
     Rotor: Normal liver color.
115. Compare AST vs. ALT in terms of organ specificity. | ALT: Liver-specific.
     AST: Heart, muscle, and mitochondria.
116. Compare HBV Immunity from infection vs. vaccine. | Infection: (+) Anti-HBs & (+) Anti-HBc.
     Vaccine: (+) Anti-HBs only.
117. Compare HAV vs. HEV in terms of risk to pregnant women. | HEV is far more dangerous.
     HEV has a 30% mortality rate in pregnancy.
118. Compare PT vs. Albumin as markers of liver function. | PT: Acute/Fulminant indicator.
     Albumin: Chronic assessment.
119. Compare Pre-hepatic vs. Post-hepatic Jaundice bilirubin and symptoms. | Pre-hepatic: Hemolysis/Indirect Bilirubin.
     Post-hepatic: Obstruction/Direct Bilirubin/Pruritus.
120. Compare HCV Quantitative vs. Qualitative Testing. | Quantitative: Monitors treatment response.
     Qualitative: Used for diagnosis.
121. Compare GGT vs. ALP in differentiating hepatic from bone disease. | GGT stays normal in bone.
     GGT confirms the hepatic origin of ALP.
122. Compare Wilson's Disease vs. Hemochromatosis primary defect. | Wilson's: Copper (low ceruloplasmin).
     Hemochromatosis: Iron overload.
123. Compare markers in the HBV Window Period. | HBsAg/Anti-HBs negative.
     IgM Anti-HBc is the only marker.